Annual Current Liabilities
$27.27 M
+$4.57 M+20.13%
December 31, 2023
Summary
- As of February 8, 2025, XENE annual total current liabilities is $27.27 million, with the most recent change of +$4.57 million (+20.13%) on December 31, 2023.
- During the last 3 years, XENE annual current liabilities has risen by +$12.49 million (+84.51%).
- XENE annual current liabilities is now -37.13% below its all-time high of $43.38 million, reached on December 31, 2019.
Performance
XENE Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$29.70 M
-$1.59 M-5.08%
September 30, 2024
Summary
- As of February 8, 2025, XENE quarterly total current liabilities is $29.70 million, with the most recent change of -$1.59 million (-5.08%) on September 30, 2024.
- Over the past year, XENE quarterly current liabilities has dropped by -$1.59 million (-5.08%).
- XENE quarterly current liabilities is now -38.80% below its all-time high of $48.52 million, reached on March 31, 2020.
Performance
XENE Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
XENE Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.1% | -5.1% |
| 3 y3 years | +84.5% | +5.5% |
| 5 y5 years | +562.1% | +5.5% |
XENE Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +90.4% | -5.1% | +272.0% |
| 5 y | 5-year | -37.1% | +90.4% | -38.8% | +272.0% |
| alltime | all time | -37.1% | +880.3% | -38.8% | +967.4% |
Xenon Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $29.70 M(-5.1%) |
| Jun 2024 | - | $31.29 M(+40.8%) |
| Mar 2024 | - | $22.22 M(-18.5%) |
| Dec 2023 | $27.27 M(+20.1%) | $27.27 M(+10.2%) |
| Sep 2023 | - | $24.74 M(-12.1%) |
| Jun 2023 | - | $28.16 M(+25.2%) |
| Mar 2023 | - | $22.49 M(-0.9%) |
| Dec 2022 | $22.70 M(+58.5%) | $22.70 M(+46.1%) |
| Sep 2022 | - | $15.54 M(+13.1%) |
| Jun 2022 | - | $13.74 M(+72.1%) |
| Mar 2022 | - | $7.98 M(-44.3%) |
| Dec 2021 | $14.32 M(-3.1%) | $14.32 M(+11.4%) |
| Sep 2021 | - | $12.86 M(-14.2%) |
| Jun 2021 | - | $14.98 M(+30.4%) |
| Mar 2021 | - | $11.49 M(-22.3%) |
| Dec 2020 | $14.78 M(-65.9%) | $14.78 M(-12.6%) |
| Sep 2020 | - | $16.92 M(-19.7%) |
| Jun 2020 | - | $21.05 M(-56.6%) |
| Mar 2020 | - | $48.52 M(+11.9%) |
| Dec 2019 | $43.38 M | $43.38 M(+270.9%) |
| Sep 2019 | - | $11.70 M(+25.4%) |
| Jun 2019 | - | $9.33 M(+46.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $6.38 M(+54.8%) |
| Dec 2018 | $4.12 M(+0.9%) | $4.12 M(-6.7%) |
| Sep 2018 | - | $4.41 M(+42.6%) |
| Jun 2018 | - | $3.09 M(-18.3%) |
| Mar 2018 | - | $3.79 M(-7.2%) |
| Dec 2017 | $4.08 M(+13.9%) | $4.08 M(+33.5%) |
| Sep 2017 | - | $3.06 M(-19.0%) |
| Jun 2017 | - | $3.77 M(+5.1%) |
| Mar 2017 | - | $3.59 M(+0.1%) |
| Dec 2016 | $3.59 M(+28.9%) | $3.59 M(-9.8%) |
| Sep 2016 | - | $3.98 M(+35.7%) |
| Jun 2016 | - | $2.93 M(+2.0%) |
| Mar 2016 | - | $2.87 M(+3.2%) |
| Dec 2015 | $2.78 M(-80.5%) | $2.78 M(-47.9%) |
| Sep 2015 | - | $5.34 M(-55.6%) |
| Jun 2015 | - | $12.02 M(+17.2%) |
| Mar 2015 | - | $10.25 M(-28.2%) |
| Dec 2014 | $14.29 M(-21.5%) | $14.29 M(-12.6%) |
| Sep 2014 | - | $16.34 M(-5.2%) |
| Jun 2014 | - | $17.23 M(-5.3%) |
| Dec 2013 | $18.20 M(-5.2%) | $18.20 M |
| Dec 2012 | $19.20 M | - |
FAQ
- What is Xenon Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual current liabilities year-on-year change?
- What is Xenon Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly current liabilities year-on-year change?
What is Xenon Pharmaceuticals annual total current liabilities?
The current annual current liabilities of XENE is $27.27 M
What is the all time high annual current liabilities for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual total current liabilities is $43.38 M
What is Xenon Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, XENE annual total current liabilities has changed by +$4.57 M (+20.13%)
What is Xenon Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of XENE is $29.70 M
What is the all time high quarterly current liabilities for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly total current liabilities is $48.52 M
What is Xenon Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, XENE quarterly total current liabilities has changed by -$1.59 M (-5.08%)